SculpSure OKed for Back, Inner and Outer Thighs

June 16, 2017

The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure’s SculpSure to treat the back and inner and outer thighs.
The SculpSure treatment is already FDA-cleared for treatment of the abdomen and love handles.
Developed by Cynosure, a division of Hologic, SculpSure utilizes a selective wavelength laser that precisely targets fat cells under the skin. The laser raises the temperature of body fat to disrupt and destroy these cells, which are naturally eliminated over time and do not return. Patients are able to achieve desired results – without downtime or surgery – through customized treatment plans, each lasting only 25 minutes.
Read more at Modern Aesthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Accepts Supplemental Biologics License Application for Botox Cosmetic for Masseter Muscle Prominence
    • Medical Spa Show Nominated for Best Tradeshow Injectable Education: 2026 L+A Clinical Collective Awards
    • AmSpa Partners with Allergan Medical Institute to Offer Members Scholarship Opportunities
    • 27-Year-Old Dies Following NAD+ Infusion at New York Wellness Center
    • Cavin CPAs & Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association